Himisha Beltran

Title: Innovations in Prostate Cancer Treatment by Himisha Beltran

Introduction

Himisha Beltran is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of cancer research, particularly in the area of prostate cancer. Her work focuses on identifying molecular markers that can aid in the prognosis and treatment of this disease.

Latest Patents

Himisha Beltran holds a patent for her invention titled "Molecular subtyping, prognosis and treatment of prostate cancer." This patent discloses new prognostic molecular markers for prostate cancer. Specifically, it identifies that overexpression or amplification of at least one of AURKA or MYCN defines a distinct subgroup of prostate cancer that is predisposed to the development of lethal neuroendocrine prostate cancer (NEPC). This subgroup is expected to benefit from early intervention, which could significantly improve patient outcomes.

Career Highlights

Beltran is affiliated with Cornell University, where she conducts her research and contributes to advancements in cancer treatment. Her work has garnered attention for its potential to change the landscape of prostate cancer management.

Collaborations

One of her notable collaborators is Mark A. Rubin, who works alongside her in the research efforts at Cornell University. Their partnership has been instrumental in driving forward the understanding of molecular subtypes in prostate cancer.

Conclusion

Himisha Beltran's innovative work in identifying molecular markers for prostate cancer represents a significant advancement in the field. Her contributions have the potential to improve prognosis and treatment strategies for patients, highlighting the importance of research in combating cancer.